SCHEMBL4892582

SCHEMBL4892582

Nc1ccc(CCNC2CC3CCC2C3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPID Q08752 1/20 0.42
LTA4H P09960 1/20 0.40
GFER P55789 1/20 0.38
NPC1 O15118 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
EPHX2 P34913 3/20 0.36
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SIGMAR1 Q99720 2/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13589885 0.84 FUCA1 (0.49) LTA4HNPC1KDM4EALDH1A1EPHX2
SCHEMBL346327 0.79 ALDH1A1 (0.54) NPC1ALDH1A1SMN1; SMN2GRIN2B
SCHEMBL18017611 0.79 HTT (0.45) KDM4EALDH1A1EPHX2TDP1HPGD
SCHEMBL14725137 0.79 ALDH1A1 (0.43) LTA4HNPC1KDM4EALDH1A1EPHX2
SCHEMBL4892673 0.76 LMNA (0.57) PPIDGFERKDM4EALDH1A1EPHX2
SCHEMBL10312481 0.71 EPHX2 (0.44) ALDH1A1EPHX2TDP1SIGMAR1GRIN2D
SCHEMBL14411949 0.70 TAAR1 (0.57) GFERKDM4EALDH1A1LMNATDP1
SCHEMBL25343480 0.69 TAAR1 (0.59) GFERNPC1KDM4ETDP1GRIN2B
SCHEMBL10876472 0.69 LTA4H (0.53) LTA4HKDM4EALDH1A1LMNAHPGD
SCHEMBL10881250 0.69 LTA4H (0.53) LTA4HKDM4EALDH1A1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE FLT3, FES, ALK PPID 2214/4885LTA4H 4440/4885GFER 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.